REQUEST A DEMO
Total
USD $0.00
Search more companies

GenoFocus, Inc. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: GenoFocus, Inc. Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

GenoFocus, Inc. is a company in South Korea, with a head office in Daejeon. The company operates in the Medicinal and Botanical Manufacturing sector. It was first established on March 29, 2000. 82 (2025) employees currently work for GenoFocus, Inc.. In its most recent financial highlights, the company reported a net sales revenue increase of 9.13% in Q12026. Its’ total assets recorded a negative growth of 2.55%. In 2026, GenoFocus, Inc.’s net profit margin decreased by 9.35%.

Headquarters
65, Techno 1-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the GenoFocus, Inc. report to view the information.

Website: http://www.genofocus.com

Basic Information
Total Employees:
Purchase the GenoFocus, Inc. report to view the information.
Outstanding Shares:
Purchase the GenoFocus, Inc. report to view the information.
Registered Capital:
Purchase the GenoFocus, Inc. report to view the information.
Financial Auditors:
Purchase the GenoFocus, Inc. report to view the information.
Incorporation Date:
March 29, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
24.6%
Purchase this report to view the information.
10.3%
Purchase this report to view the information.
0.2%
Subsidiaries
Genofocus Biotechnology Inc
100%
주식회사 바이옴로직
100%
주식회사 지에프퍼멘텍
67.39%
Company Performance
Financial values in the chart are available after GenoFocus, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
9.13%
Total Operating Revenue
5.01%
Operating Profit
-35.76%
Net Profit/Loss for the Period
-101.62%
Total Assets
-2.55%
Total Equity
97.36%
Operating Profit Margin
-3.24%
Net Profit Margin
-9.35%
Return on Equity (ROE)
-0.09%
Debt / Equity
-60.16%
Quick Ratio
-0.17%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?